Ginkgo Bioworks Holdings Inc vs eBay Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while eBay Inc trades at $113.22 (market cap $49.97B). The key difference: eBay Inc is far larger — about 84.6× Ginkgo Bioworks Holdings Inc's market cap, and eBay Inc pays a 1.1% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | EBAY | |
|---|---|---|
Market Cap | $590.53M | $49.97B |
Sector | Health | Consumer Cyclical |
52-Week High | $16.14 | $118.96 |
52-Week Low | $5.48 | $76.79 |
Enterprise Value | $627.78M | $53.31B |
Volume | — | 5,186,418 |
Dividend Yield | — | 1.1% |
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
EBAY trades at $115.09, down 1.8% today, amid a bullish technical setup with strong moving average signals and key support at $114. The company shows robust profitability with a 71.79% gross margin and consistent earnings beats, while navigating a potential acquisition by GameStop. Revenue growth is steady, reaching $11.10B in 2025, though net cash flow turned negative.
Outlook remains mixed: strong fundamentals and bullish analyst sentiment (46% buy ratings) support upside, but risks include the uncertain GameStop takeover bid and competitive pressures. The stock trades above the $107.82 consensus target, suggesting limited near-term gains unless earnings surprise again.
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →